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Whole genome sequencingBackground: By using whole genome sequencing (WGS), researchers are beginning to
understand the genetic diversity of Mycobacterium tuberculosis (MTB) and its consequences
for the diagnosis of multidrug-resistant tuberculosis (MDR–TB) on a genomic scale. The
Global Consortium for Drug-resistant TB Diagnostics (GCDD) conducted a genome scale
variant analyses of 366 clinical MTB genomes (mostly MDR/XDR [extensively drug resis-
tant]) from four countries in order to inform the development of rapid molecular diagnos-
tics. This project has been extended by performing an evolutionary analysis of isoniazid
(INH)-resistant isolates for prognostic purposes.
Methods: 151 (130 INHR, 21 INHS) clinical MTB isolates from India (19: 17 INHR, 2 INHS),
Moldova (48: 42 INHR, 6 INHS), the Philippines (26: 20 INHR, 6 INHS), and South Africa
(58: 51 INHR, 7 INHS) were included in this study. INH drug susceptibility was determined
by using MGIT 960 and WHO (World Health Organization)-recommended critical concen-
tration of 0.1 mg/L. Isolates were sequenced using PacBio RS WGS platform. A genome-
wide variant analysis was conducted using a proprietary pipeline (PacDAP) developed at
San Diego State University. To infer the amino acid changes in katG that confer resis-
tance, PAML was utilized to detect sites in silico that are under positive selection. The
dN/dS method was used in combination with Bayes empirical Bayes to determine sites
under positive selection and Chi-Squared analysis to determine the significance of the
selected sites.
Results: PacDAP variant analysis revealed 22 novel catalase-peroxidase (katG product)
mutations. Of these, 14 were single nucleotide polymorphisms, while 8 novel mutations
appeared in combination with katG S315T and/or with inhA promoter C-15T. These SNPs
have not been previously reported. Additionally, 11 previously observed, but uncommon,
katG mutations were also observed in these clinical isolates. These results suggest that 17
amino acids in the enzyme are under positive selective pressure; most significantly in
South Africa and the Philippines. No selective pressure on codons other than 315 was
observed in isolates from Moldova. Due to the low number of isolates from India, the sig-
nificance of the sites under positive selection was low and no prediction for India could
be made based on this study.
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remaining 8 combinatorial mutations are either compensatory in nature or, in combina-
tion with known SNPs, could increase resistance levels. Positive selection results indicate
a diversifying evolutionary path to resistance more in line with long tail statistics and
therefore indicate a departure from the traditional point mutation (or ‘‘hotspot’’) model
that current molecular diagnostics are based on. Positive selection pressures indicate a
future with elevated diagnostic and prognostic significance of the ‘‘long tail’’ (i.e., alterna-
tive mechanisms of resistance) and potentially diminishing significance of the canonical
mutations (especially in South Africa and the Philippines), which could have significant
future implications on narrowly targeting molecular diagnostics.
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